The adverse renal effects of prostaglandin-synthesis Inhibitors in the newborn rabbit

Seminars in Perinatology

Volumn 26, Issue 6, 2002, Pages 398-405

  Guignard, Jean Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ACETYLSALICYLIC ACID; IBUPROFEN; INDOMETACIN; INULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HYDRAMNIOS; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; NEWBORN; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RABBIT; URINE FLOW RATE; VASOCONSTRICTION; VASODILATATION;

EID: 0036969193     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2002.37310     Document Type: Conference Paper

References (55)

1. Sawdy R, Slater D, Jones G, et al: Use of a cyclooxygenase Type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 350:265-266, 1997
2. Cabrol D, Landesman R, Muller J, et al: Treatment of polyhydraninos with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol 157:422-426, 1987
3. Heymann MA, Rudolph AM, Silverman NH: Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 295:530-533, 1976
4. Friedman WF, Hirschklau MJ, Printz MP, et al: Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 295:526-529, 1976
5. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231:232-235, 1971
6. Moïse KJ, Ou CN, Kirshon B, et al: Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol 162:549-554, 1990
7. Van der Heijden AJ, Calus C, Narcy F, et al: Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 171:617-623, 1994
8. Komhoff M, Wang JL, Chang HF, et al: Cyclooxygenases-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57:414-422, 2000
9. Gleason CA: Prostaglandins and the developing kidney. Sem Perinatol 11:12-21, 1987
10. Simeoni U, Messer J, Weisburd P, et al: Neonatal renal function and intrauterine exposure to prostaglandin synthesis inhibitors. Eur J Pediatr 148:371-375, 1989
11. Kaplan BS, Restaino I, Raval DS, et al: Renal failure in the neonate associated with in utero exposure to nonsteroidal anti-inflammatory agents. Pediatr Nephrol 8:700-704, 1994
12. Cifuentes PF, Olley PM, Balfe JW: Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 95:583-587, 1979
13. John EG, Vasan U, Hastreiter AR, et al: Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus. Pediatr Pharmacol 4:11-19, 1984
14. Catterton Z, Sellers B, Gray B: Inulin clearance in the premature infant receiving indomethacin. J Pediatr 96: 737-739, 1980
15. Gouyon JB, Chouchane M, Françoise M: Effects rénaux d'un traitement prolongé par indométacine chez le prématuré. Arch Pédiatr 1:894-897, 1994
16. Winther JB, Hoskins E, Printz MP, et al: Influence of indomethacin on renal function in conscious newborn lambs. Biol Neonate 38:76-84, 1980
17. Gleason CA, Clyman RI, Heymann MA, et al: Indomethacin and patent ductus arteriosus: effects on renal function in preterm lambs. Am J Physiol 254:F38-F44, 1988
18. Duarte-Silva M, Gouyon JB, Guignard JP: Renal effects of indomethacin and dopamine in newborn rabbits. Kidney 30:455-456, 1986
19. Varvarigou A, Bardin CL, Beharry K, et al: Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 275:539-544, 1996
20. Van Overmeire B, Smets K, Lecoutere D, et al: A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674-681, 2000
21. Salame Chamaa N, Mosig D, Drukker A, Guignard JP: The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 48:600-605, 2000
22. Gouyon JB, Vallotton M, Guignard JP: The newborn rabbit: A model for studying hypoxemia-induced renal changes. Biol Neonate 52:115-120, 1987
23. Wright HK, Gann DS: An automatic anthrone method for the determination of inulin in plasma and urine. J Lab Clin Med 67:689-693, 1966
24. Bratton AC, Marshall EK: A new coupling component for sulfanilamide determination. J Biol Chem 128:537-550, 1939
25. Gouyon JB, Guignard JP: Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits. Kidney Int 33:1078-1083, 1988
26. Smith W: Prostanoid biosynthesis and mechanisms of action. Am J Physiol 263:F181-F191, 1992
27. Whelton A: Nephrotoxicity of non-steroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106:S13-S24, 1999
28. Guignard JP, Gouyon JB, EG: Vasoactive factors in the immature kidney. Pediatr Nephrol 5:443-446, 1991
29. Semmekrot B, Guignard JP: Atrial natriuretic peptide during early human development. Biol Neonate 60:341-349, 1991
30. Toth-Heyn P, Guignard JP: Bradykynin in the newborn kidney: Nephron 31:571-575, 2002
31. Ballèvre, L, Sohlaug M, Guignard JP: Nitric oxide and the immature kidney. Biol Neonate 70:1-14, 1996
32. Kastner PR, Hall JE, Guyton AC: Control of glomerular filtration rate: role of intrarenally formed angiotensin II. Am J Physiol 246:F897-F906, 1984
33. Semama D, Thonney M, Guignard JP: Role of endothelin in renal haemodynamics of newborn rabbits. Pediatr Nephrol 7:886-890, 1993
34. Drukker A, Mosig D, Guignard JP: The renal effects of Aspirin in newborn and young adult rabbits. Pediatr Nephrol 16:713-718, 2001
35. Van der Heijden AJ, Provoost AP, Nauta J, et al: Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res 24:644-648, 1988
36. Pomerantz A, Korsetz Z, Dolfin Z, et al: Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent. Nephrol Dial Transplant 11:1139-1141, 1990
37. Kirshon B, Moïse KJ, Mari G, et al: Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios. Am J Perinatol 8:86-88, 1991
38. Bueva A, Guignard JP: Renal function in preterm neonates. Pediatr Res 36:572-577, 1994
39. Guignard JP, Drukker A: Why do newborn infants have a high plasma creatinine? Pediatrics 103:e49, 1999
40. Gallini F, Maggio L, Romagnoli C, et al: Progression of renal function in premature neonates with gestational age < 32 weeks. Pediatr Nephrol 15:119-124, 2000
41. Matos P, Duarte-Silva M, Drukker A, et al: Creatinine reabsorption by the newborn rabbit kidney. Pediatr Res 44:639-641, 1998
42. Cotton RB: Don't discard your indomethacin yet. Acta Paediatr 89:1278-1279, 2000
43. Drukker A, Guignard JP: Ibuprofen-lysine for closure of patent ductus arteriosus. Acta Paediatr Scand 90:465-466, 2001
44. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases-1 and -2. Annu Rev Pharmacol Toxicol 38:97-120, 1998
45. Harris CJ, Brater DC: Renal effects of cyclooxygenase-2 selective inhibitors. Curr Opin Nephrol Hypertens 10: 603-610, 2001
46. Perazella MA, Eras J: COX-2 inhibitors and acute renal failure. Am J Kidney Dis 35:937-940, 2000
47. Dunn MJ (Editorial): Are COX-2 selective inhibitors nephrotoxic? Am J Kidney Dis 35:976-977, 2000
48. Harris RC: Cyclooxygenase-2 in the kidney. J Am Soc Nephrol 11:2387-2394, 2000
49. Buttar NS, Wang KK: The "Aspirin" of the new millennium: cyclooxygenase-2 inhibitors. Mayo Clin Pros 75: 1027-1038, 2000
50. Dinchuk JE, Car BD, Focht RJ, et al: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406-409, 1995
51. Zhang MZ, Wang JL, Cheng HF, et al: Cyclooxygenase-2 in rat nephron development. Am J Physiol 273:F994-F1002, 1997
52. Kömhoff M, Grone HJ, Klein T, et al: Localization of cyclooxygenases-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 272: F460-F468, 1997
53. Peruzzi L, Gianoglio B, Porcellini MC, et al: Neonatal end-stage renal failure associated with maternal ingestion of cyclooxygenase-Type-2 selective inhibitor nimesulide as tocolytic. Lancet 354:1615, 1999
54. Balasubramaniam J: Nimesulide and neonatal renal failure. Lancet 355:575, 2000
55. Prévot A, Mosig D, Martini S, et al: Renal effects of cyclooxygenase-Type-2 (COX-2) inhibition with nimesulide in the newborn rabbit. Swiss Med Wkly 131 (suppl 128), 2001